US Patent 9974817 Method of treatment using

Patent 9974817 was granted and assigned to University of Tartu on May, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

University of Tartu

Current Assignee

University of Tartu

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9974817

Date of Patent

May 22, 2018

Patent Application Number

14655328

Date Filed

December 20, 2013

Patent Primary Examiner

‌

Brian Gangle

Patent abstract

The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component, a metabolic syndrome related disorder selected from prediabetes, type 2 diabetes and cardiovascular disease. The effect may be achieved by simultaneously: decreasing the level of glycated haemoglobin HbA1c, decreasing or preventing low-grade inflammation on a cellular level and increasing the level of adiponectin.